Filgotinib shows improvements in rheumatoid arthritis trial
Mark Genovese led an international trial of filgotinib that improved the condition of rheumatoid arthritis patients who failed other therapies. Credit: Norbert von der Groeben.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more